ESMO Symposium on Immuno-Oncology 2014

Oncology Meeting Resources

21 Nov - 22 Nov, Geneva, Switzerland

ESMO Symposium on Immuno-Oncology 2014

Abstracts from the ESMO Symposium on Immuno-Oncology 2014 are now available here. Presentations and webcasts from the meeting will be available shortly after the Symposium.

Presenter Presentation title Session title
Rolf A. Stahel Welcome and introduction Welcome and introduction
James Yang Adoptive immunotherapy Opening Keynote lecture
Aude Chapuis Targeting leukemia with TCR transduced t-cells Haematological malignancies & myeloma
Marcela Maus CD19 targeted T-cell therapy Haematological malignancies & myeloma
Reno Debets T cell therapy towards solid tumors: is it all about the antigen? Cancer antigens: New horizons
John Haanen Defining the role of mutated antigens Cancer antigens: New horizons
Benoit J. Van den Eynde Alternative tumour antigens and the tumour proteasome Cancer antigens: New horizons
Robert Hawkins Clinical development of adoptive cell therapy T-cell engineering
Nathalie Rufer Developing T cell receptors with improved affinity T-cell engineering
Hideho Okada Invited Discussant, abstract 1O Best Abstracts Session
Eric Raymond Invited Discussant, abstract 3O Best Abstracts Session
John Haanen Invited Discussant, abstract 4O Best Abstracts Session
Anna Berghoff 1O - Role of PDL1 expression and tumor infiltrating lymphocytes (TILs) in glioblastoma (GBM) and brain metastases (BM) Best Abstracts Session
Daniela Thommen 2O - Activation of T cells upon treatment with bispecific antibodies correlates with the expression of co-inhibitory receptors on tumor-infiltrating lymphocytes in human lung cancer Best Abstracts Session
Werner Scheithauer 3O - Long-term maintenance therapy with the TLR-9 agonist MGN1703 in a subgroup of metastatic colorectal cancer patients from the IMPACT study Best Abstracts Session